Updates are available Correction dated 2025-01-17
Click to view Correction: https://doi.org/10.1038/s41467-025-55964-1
-
Authors
Atz, Kenneth https://orcid.org/0000-0002-2628-1619
Cotos, Leandro
Isert, Clemens https://orcid.org/0000-0002-4176-7887
Håkansson, Maria
Focht, Dorota
Hilleke, Mattis https://orcid.org/0009-0005-3210-7309
Nippa, David F. https://orcid.org/0000-0002-0346-3786
Iff, Michael
Ledergerber, Jann https://orcid.org/0009-0004-9774-095X
Schiebroek, Carl C. G. https://orcid.org/0009-0007-3516-1508
Romeo, Valentina
Hiss, Jan A. https://orcid.org/0000-0003-0559-4330
Merk, Daniel https://orcid.org/0000-0002-5359-8128
Schneider, Petra https://orcid.org/0000-0001-8296-6105
Kuhn, Bernd
Grether, Uwe https://orcid.org/0000-0002-3164-9270
Schneider, Gisbert https://orcid.org/0000-0001-6706-1084
-
Funding
Funding for this research was provided by:
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (CRSII5_202245)
Scholarship Fund of the Swiss Chemical Industry
- License Information
-
More Information
Article History
Received: 13 September 2023
Accepted: 2 April 2024
First Online: 22 April 2024
Change Date: 17 January 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41467-025-55964-1
Competing interests
: G.S. and P.S. declare a potential financial and non-financial conflict of interest as co-founders of inSili.com LLC, Zurich, and in their role as scientific consultants to the pharmaceutical industry. D.F.N., V.R., U.G. and B.K. declare potential financial and non-financial conflict of interest as full employees of F. Hoffmann-La Roche Ltd. M.Hå. and D.F. declare potential financial and non-financial conflict of interest as full employees of SARomics Biostructures AB. K.A., L.C., C.I., M.Hi., J.L., C.C.G.S., J.A.H. and D.M. declare no competing interest.
